Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BeiGene Ltd ADR buy skatcup

Start price
€244.00
23.01.23 / 50%
Target price
€150.00
23.01.24
Performance (%)
-38.11%
End price
€151.00
24.01.24
Summary
This prediction ended on 24.01.24 with a price of €151.00. Massive losses of -38.11% were the result for the BUY prediction by skatcup. skatcup has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BeiGene Ltd ADR 4.839% 4.839% -44.444%
iShares Core DAX® 1.051% -1.833% 12.822%
iShares Nasdaq 100 -0.547% -3.738% 40.625%
iShares Nikkei 225® -1.778% -8.115% 16.092%
iShares S&P 500 0.002% -2.226% 28.387%

According to skatcup what are the pros and cons of BeiGene Ltd ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Cons

Comments by skatcup for this prediction

In the thread Beigene Ltd ADR diskutieren
Prediction Buy
Perf. (%) -38.11%
Target price 260.000
Change
Ends at 23.01.24

Buy mit Kursziel 260,0

Prediction Buy
Perf. (%) -38.11%
Target price 220.000
Change
Ends at 23.01.24

Kursziel geändert auf 220,0

Prediction Buy
Perf. (%) -38.11%
Target price 150.000
Change
Ends at 23.01.24

Kursziel geändert auf 150,0

In the thread Trading Beigene Ltd ADR
Prediction Buy
Perf. (%) -38.11%
Target price 150.000
Change
Ends at 23.01.24

Die von skatcup gewählte maximale Laufzeit wurde überschritten

Stopped prediction by skatcup for BeiGene Ltd ADR

buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€148.00
25.02.20
€344.00
04.11.21
117.57%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model